We will calculate the number of participants who talk to the research pharmacist during the course of the intervention.
| Group | Value | 95% CI |
|---|---|---|
| Research Pharmacist Monitoring | 20 |
Last reviewed · How we verify
A Pharmacist Intervention to Improve Mother and Child Health
NA trial testing Research Pharmacist in Hypertension in 25 participants. Completed in 10 July 2024.
| Lead sponsor | University of Iowa |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 25 |
| Start date | 30 January 2024 |
| Primary completion | 10 July 2024 |
| Estimated completion | 10 July 2024 |
| Sites | 1 location across United States |
University of Iowa
Adults 18 to 55, female only, with Hypertension. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
We will calculate the number of participants who talk to the research pharmacist during the course of the intervention.
| Group | Value | 95% CI |
|---|---|---|
| Research Pharmacist Monitoring | 20 |
We will calculate the number of participants who return at least one blood pressure measurement via text message.
| Group | Value | 95% CI |
|---|---|---|
| Research Pharmacist Monitoring | 22 |
We will calculate the percentage of well-child visits that are attended by each family.
| Group | Value | 95% CI |
|---|---|---|
| Research Pharmacist Monitoring | 57 |
We will calculate the percentage of vaccinations received by each child.
| Group | Value | 95% CI |
|---|---|---|
| Research Pharmacist Monitoring | 251 |
We will calculate the number of blood pressure values that are submitted by each participant.
| Group | Value | 95% CI |
|---|---|---|
| Research Pharmacist Monitoring | 12.9 | ± 5.3 |
We will determine how many participants' blood pressure is controlled after the intervention.
| Group | Value | 95% CI |
|---|---|---|
| Research Pharmacist Monitoring | 12 |
We will measure participant satisfaction with the study using an exit survey. Satisfaction will be measured by a response of Extremely Helpful or Helpful on the question- My contact(s) with the pharmacist about my health were....
| Group | Value | 95% CI |
|---|---|---|
| Research Pharmacist Monitoring | 7 |
The goal of this clinical trial is to learn if a research pharmacist can improve the health of new mothers and their babies. The main questions it aims to answer are: * Will postpartum women who had elevated blood pressure during pregnancy be willing to participate in the study, talk to a pharmacist about their health and the health of their child, and text us their blood pressure measurements? * Will contact with the pharmacist improve the health of the mother and/or the child? Participants will: * complete a baseline demographic survey, * be given a blood pressure cuff and taught how to use it, * be asked to text us their blood pressure values 2 times per day for 7 days after enrollment, * complete a phone call with a pharmacist discussing their health and the health of their baby, * text us their blood pressure 1 time per day for 3 days 1 month after enrollment, * have a 1 month follow-up phone call with the research pharmacist, and * complete an exit survey to provide feedback about the study.
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06073054.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing